Rani E. George

9.3k total citations · 3 hit papers
55 papers, 4.9k citations indexed

About

Rani E. George is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rani E. George has authored 55 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 30 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Rani E. George's work include Neuroblastoma Research and Treatments (42 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Protein Degradation and Inhibitors (9 papers). Rani E. George is often cited by papers focused on Neuroblastoma Research and Treatments (42 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Protein Degradation and Inhibitors (9 papers). Rani E. George collaborates with scholars based in United States, United Kingdom and Netherlands. Rani E. George's co-authors include Satyaki Sengupta, A. Thomas Look, Guo‐Cheng Yuan, Nathanael S. Gray, Kwok‐Kin Wong, Lisa Diller, Rodney A. Stewart, Ruben Dries, Bandana Sharma and Antonio R. Pérez‐Atayde and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

Rani E. George

55 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis

2018 567 citations Rani E. George, Kwok‐Kin Wong et al. profile →
Giotto: a toolbox for integrative analysis and visualization of spatial expression data

2021 510 citations Ruben Dries, Qian Zhu et al. Genome biology profile →
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer

2014 451 citations Edmond Chipumuro, Eugenio Marco et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rani E. George United States	30	3.4k	1.5k	1.4k	1.1k	472	55	4.9k
Jan J. Molenaar Netherlands	32	1.8k 0.5×	1.5k 1.0×	932 0.7×	894 0.8×	296 0.6×	91	3.2k
Håkan Axelson Sweden	37	2.8k 0.8×	554 0.4×	1.4k 1.0×	885 0.8×	524 1.1×	90	4.1k
Yaël P. Mossé United States	35	2.4k 0.7×	2.7k 1.8×	1.7k 1.2×	1.3k 1.2×	706 1.5×	96	4.6k
Erik Fredlund Sweden	26	3.0k 0.9×	562 0.4×	2.5k 1.8×	1.0k 1.0×	332 0.7×	36	4.6k
Meredith S. Irwin Canada	43	4.2k 1.2×	1.9k 1.3×	1.5k 1.1×	3.1k 2.8×	358 0.8×	124	6.7k
Genglin Jin United States	15	3.0k 0.9×	456 0.3×	2.4k 1.8×	666 0.6×	864 1.8×	22	5.8k
Peter van Sluis Netherlands	25	2.6k 0.8×	1.5k 1.0×	919 0.7×	573 0.5×	168 0.4×	35	3.5k
Keishi Makino Japan	27	1.5k 0.4×	608 0.4×	583 0.4×	1.0k 0.9×	912 1.9×	95	4.2k
Thomas G. P. Grünewald Germany	37	2.7k 0.8×	367 0.2×	1.1k 0.8×	1.0k 1.0×	1.0k 2.2×	103	4.4k
Joon H. Uhm United States	37	1.7k 0.5×	527 0.4×	1.1k 0.8×	907 0.8×	764 1.6×	127	4.4k

Countries citing papers authored by Rani E. George

Since Specialization

Citations

This map shows the geographic impact of Rani E. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rani E. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rani E. George more than expected).

Fields of papers citing papers by Rani E. George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rani E. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rani E. George. The network helps show where Rani E. George may publish in the future.

Co-authorship network of co-authors of Rani E. George

This figure shows the co-authorship network connecting the top 25 collaborators of Rani E. George. A scholar is included among the top collaborators of Rani E. George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rani E. George. Rani E. George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cornel, Annelisa M., Satyaki Sengupta, Judith Wienke, et al.. (2022). Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch. Journal for ImmunoTherapy of Cancer. 10(12). e005002–e005002. 22 indexed citations

Dries, Ruben, Qian Zhu, Rui Dong, et al.. (2021). Giotto: a toolbox for integrative analysis and visualization of spatial expression data. Genome biology. 22(1). 78–78. 510 indexed citations breakdown →

Cohen, Malkiel A., Shupei Zhang, Satyaki Sengupta, et al.. (2020). Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras. Cell stem cell. 26(4). 579–592.e6. 26 indexed citations

Bayles, Ian, Małgorzata Krajewska, William Pontius, et al.. (2019). Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma. Journal of Clinical Investigation. 129(10). 4377–4392. 34 indexed citations

Krajewska, Małgorzata, Ruben Dries, Andrew V. Grassetti, et al.. (2019). CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation. Nature Communications. 10(1). 1757–1757. 181 indexed citations

Sun, Michael, Ngoc T. Ha, Duc-Hung Pham, et al.. (2017). Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells. Scientific Reports. 7(1). 42888–42888. 16 indexed citations

Sengupta, Satyaki & Rani E. George. (2017). Super-Enhancer-Driven Transcriptional Dependencies in Cancer. Trends in cancer. 3(4). 269–281. 230 indexed citations

Chipumuro, Edmond, Eugenio Marco, Camilla L. Christensen, et al.. (2014). CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

Chipumuro, Edmond, Eugenio Marco, Camilla L. Christensen, et al.. (2014). CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. Cell. 159(5). 1126–1139. 451 indexed citations breakdown →

10.

Jamin, Yann, Albert Hallsworth, Rani E. George, et al.. (2014). Intrinsic Susceptibility MRI Identifies Tumors with ALKF1174L Mutation in Genetically-Engineered Murine Models of High-Risk Neuroblastoma. PLoS ONE. 9(3). e92886–e92886. 13 indexed citations

11.

Zhu, Shizhen, Jeong-Soo Lee, Feng Guo, et al.. (2012). Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis. Cancer Cell. 21(3). 362–373. 235 indexed citations

12.

George, Rani E., Lisa Diller, & Mark L. Bernstein. (2010). Pharmacotherapy of neuroblastoma. Expert Opinion on Pharmacotherapy. 11(9). 1467–1478. 20 indexed citations

13.

García, Idoia, Eva Rodríguez, Mariona Suñol, et al.. (2010). Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Molecular Cancer. 9(1). 277–277. 52 indexed citations

14.

Volchenboum, Samuel L., Cheng Li, Shuli Li, et al.. (2009). Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis. Cancer Research. 69(10). 4143–4149. 21 indexed citations

15.

Webb, Thomas R., Rani E. George, A. Thomas Look, et al.. (2009). Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Review of Anticancer Therapy. 9(3). 331–356. 183 indexed citations

16.

Schlisio, Susanne, Rajappa S. Kenchappa, Liesbeth C.W. Vredeveld, et al.. (2008). The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes & Development. 22(7). 884–893. 257 indexed citations

17.

Hansford, Loen M., Amy E. McKee, Libo Zhang, et al.. (2007). Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell. Cancer Research. 67(23). 11234–11243. 132 indexed citations

18.

George, Rani E., Edward F. Attiyeh, Shuli Li, et al.. (2007). Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays. PLoS ONE. 2(2). e255–e255. 82 indexed citations

19.

Stewart, Rodney A., Brigitte L. Arduini, Stéphane Berghmans, et al.. (2006). Zebrafish foxd3 is selectively required for neural crest specification, migration and survival. Developmental Biology. 292(1). 174–188. 151 indexed citations

20.

Cin, Paola Dal, Leonard Atkins, Scott A. Armstrong, et al.. (2001). Amplification ofAML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes and Cancer. 30(4). 407–409. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact